ʻO ka loaʻa ʻana o nā axillary lymph nodes me ka hoʻohana ʻana i nā lepili radio-frequency identification (RFID) he lāʻau palekana a hiki ke hana no ka maʻi ʻaʻai umauma, i kākau ai kekahi kanaka noiʻi Pelekane ma kahi ʻatikala i paʻi ʻia ma Clinical Radiology.
Ua ʻike nā kānaka noiʻi i alakaʻi ʻia e Kauka Simon Lowes o ka Halemai o Queen Elizabeth ma Gateshead (ʻākau hikina o ʻEnelani)Nā lepili RFIDhiki ke hoʻohana ʻia e ʻimi uea ʻole i nā axillary lymph nodes i nā poʻe maʻi e hana ana i ka ultrasound umauma a me nā mammograms dual-view. ua kākau ka hui noiʻi. "Kōkua ka ʻikepili o kēia manawa i ke kākoʻo ʻana i ka hoʻopili palekana a me ka pono o nā lepili RFID no ka localization o nā axillary lymph nodes.
I nā makahiki i hala iho nei, ua nui ka hoihoi i ka hoʻohana ʻana i ka ʻenehana wahi uea ʻole e ʻike pono i nā lymph nodes i loko o ka maʻi ʻaʻai umauma. Ua manaʻo nā mea noiʻi e hiki i nā mea ʻē aʻe uea ʻole e like me nā lepili RFID ke hōʻoluʻolu i nā pilikia hiki no nā radiologists a me nā kauka ʻokiʻoki i ka mālama ʻana i ka maʻi ʻaʻai umauma, a ʻo ka localization maikaʻi o nā lymph nodes hiki ke kōkua i nā maʻi maʻi ʻaʻai umauma e hoʻomohala i nā hoʻolālā lapaʻau maikaʻi a pale i ka overtreatment. Ua ʻike ʻo Lowes a me nā hoa hana he aneane ʻole ka ʻikepili ma ka localization uea ʻole o nā axillary lymph nodes, me ka hoʻohana ʻana i nā lepili RFID i hoʻokomo ʻia i loko o nā wahi hoʻāʻo umauma. No ka hoʻohui ʻana i nā palapala e kū nei, ua noiʻi lākou i ka palekana a me ka hiki ke hoʻohana i nā lepili RFID e ʻike i nā axillary lymph nodes. Ua hoʻohana lāua ʻelua i kahi lepili RFID passive 11 mm x 2 mm i hoʻouka mua ʻia ma luna o kahi ʻōnaehana nila 12-gauge (LOCazer, Hologic) e hoʻohana ana i ka hoʻolaha percutaneous i alakaʻi ʻia e ke kiʻi. A laila ua hōʻoia ʻia ke kau ʻana o ka lepili e ka ultrasound a me ka mammography dual-view. Loaʻa i kēlā me kēia lepili kahi helu ʻike ʻelima helu kū hoʻokahi, kahi i hoʻouna ʻia ma o kahi mea heluhelu lima. Hōʻike pū ka mea heluhelu i ka mamao manawa maoli ma waena o ka mea ʻike a me kēlā me kēia lepili, pololei i ka pae millimeter.
Ua hoʻokomo pū ʻia ke aʻo ʻana i ka ʻikepili mai nā hoʻokomo mua ʻana o ka RFID-targeted axillary node 75 ma waena o 2019 a me 2022; i loko o kēia wā, ua hoʻolaha ʻia he 1,296 mau hōʻailona umauma a me axillary i 1,120 mau maʻi (ka maʻi ʻaʻai umauma e loaʻa ana i ka chemotherapy neoadjuvant. Hoʻokomo ka mea maʻi i ka hōʻailona RFID ma hope o ka hoʻopau ʻana i ka lāʻau lapaʻau). Ua hoʻokomo ʻia nā hōʻailona ma ka awelika o 11 mau lā ma mua o ke ʻoki kino. No nā hōʻailona underarm 75, ua hōʻike ʻo 70 i ka maʻi ʻaʻai umauma mua a ʻaʻole i hōʻike ʻo 5 i ka maʻi ʻaʻai. No nā pūlima 70 e hōʻike ana i ka maʻi ʻaʻai umauma, ua hōʻike ʻo 20 i ka pono no ka chemotherapy neoadjuvant. Hōʻike ka hui i kahi helu holomua 100 pakeneka no ka hoʻolaha ʻana o ka hōʻailona RFID. I ka manawa like, ua ʻike pū ka hui ua wehe pono ʻia nā hōʻailona āpau a me kā lākou mau lymph node axillary me ka ʻole o nā pilikia koʻikoʻi. "ʻEhā mau hihia o ka neʻe ʻana o ka lepili i ka wā o ka resection, akā ma ke ʻano holoʻokoʻa, ʻaʻole kēia i hoʻopilikia i ka lepili a i ʻole ka hoʻōla ʻana o ka lymph node," i kākau ai ʻo Lowes a me nā hoa hana.
Manaʻo nā mea kākau o ke aʻo ʻana ma muli o kā lākou mau ʻike, i hui pū ʻia me ka ʻikepili mai nā haʻawina mua, pono e hana pū nā hui o nā loea lapaʻau e mālama ana i nā wahine me ka maʻi ʻaʻai umauma e hoʻoholo i ka ʻenehana wahi uea ʻole e hoʻohana ʻia. Ua kuhikuhi pū ʻia ʻoiai ʻo nā mea hana uea ʻole āpau he mau pono a me nā pōʻino, i ka wā e pili ana i nā ʻeha umauma, hana maikaʻi lākou no ka ʻimi ʻana i nā axillary lymph nodes.
Ka manawa hoʻouna: Iune-30-2023
